Flow-cytometric plots of platelet activation, as measured by monoclonal anti-CD62P antibodies, in a normoprolactinemic subject (a), a patient with monomeric hyperprolactinemia (b), and a macroprolactinemic patient (c). ADP-stimulated expression was greater in both monomeric hyperprolactinemic patients and those with macroprolactinemia compared with controls (P = 0.005 and P = 0.003, respectively), but expression did not differ significantly between the hyperprolactinemic and macroprolactinemic subgroups (P = 0.90) 
